Carisma Therapeutics
Carisma Therapeutics is a biotechnology company founded in 2016 to bring the potheyr of adoptive cellular immunotherapy to solid tumor patients through a novel platform using chimeric antigen receptor macrophages (CARMA).
2
Funding Rounds
$112.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ma******* Ch**** | - | - | |
| Bj**** Od****** | - | - | |
| Br**** Mo****** | - | - | |
| Ch****** Ug***** | - | - | |
| St**** Ke*** | - | - | |
| Re**** Ho**** | - | - |
Funding series
Funding Series Analysis
The company Carisma Therapeutics has raised a total of $59m in funding over 2 rounds.
Key Insights:
- Carisma Therapeutics Series B round, March 2021: $59m
- Carisma Therapeutics Series A round, June 2018: $53m
Carisma Therapeutics Series B round, March 2021
$59m
Carisma Therapeutics Series A round, June 2018
$53m
Industries
Carisma Therapeutics is active in the following industries: